196 related articles for article (PubMed ID: 18775443)
1. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.
Gjoni T; Urwyler S
Neuropharmacology; 2008 Dec; 55(8):1293-9. PubMed ID: 18775443
[TBL] [Abstract][Full Text] [Related]
2. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
Gjoni T; Urwyler S
Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
Urwyler S; Gjoni T; Koljatić J; Dupuis DS
Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
[TBL] [Abstract][Full Text] [Related]
4. The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.
Gjoni T; Desrayaud S; Imobersteg S; Urwyler S
J Neurochem; 2006 Mar; 96(5):1416-22. PubMed ID: 16441514
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
6. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
[TBL] [Abstract][Full Text] [Related]
7. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
[TBL] [Abstract][Full Text] [Related]
8. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.
Lhuillier L; Mombereau C; Cryan JF; Kaupmann K
Neuropsychopharmacology; 2007 Feb; 32(2):388-98. PubMed ID: 16710312
[TBL] [Abstract][Full Text] [Related]
9. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
10. The GABA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
[TBL] [Abstract][Full Text] [Related]
12. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.
Halbout B; Quarta D; Valerio E; Heidbreder CA; Hutcheson DM
Addict Biol; 2011 Jul; 16(3):416-27. PubMed ID: 21309927
[TBL] [Abstract][Full Text] [Related]
13. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
Slattery DA; Markou A; Froestl W; Cryan JF
Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
[TBL] [Abstract][Full Text] [Related]
15. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro.
Chen K; Li HZ; Ye N; Zhang J; Wang JJ
Brain Res Bull; 2005 Oct; 67(4):310-8. PubMed ID: 16182939
[TBL] [Abstract][Full Text] [Related]
16. The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice.
Zemoura K; Ralvenius WT; Malherbe P; Benke D
Neuropharmacology; 2016 Sep; 108():172-8. PubMed ID: 27108932
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of the neural circuits activated by a GABA
Pizzo R; O'Leary OF; Cryan JF
Neuropharmacology; 2018 Jul; 136(Pt A):129-145. PubMed ID: 28734870
[TBL] [Abstract][Full Text] [Related]
18. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.
Brown JW; Moeller A; Schmidt M; Turner SC; Nimmrich V; Ma J; Rueter LE; van der Kam E; Zhang M
Neuropharmacology; 2016 Feb; 101():358-69. PubMed ID: 26471422
[TBL] [Abstract][Full Text] [Related]
20. GABAB receptor transduction mechanisms, and cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons of the rat nucleus basalis of Meynert.
Kubota H; Katsurabayashi S; Moorhouse AJ; Murakami N; Koga H; Akaike N
J Physiol; 2003 Aug; 551(Pt 1):263-76. PubMed ID: 12815184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
